当前位置:首页 - 行情中心 - 拓新药业(301089) - 财务分析

拓新药业

(301089)

  

流通市值:24.33亿  总市值:33.84亿
流通股本:9097.55万   总股本:1.27亿

拓新药业(301089)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润-0.03亿元,每股收益-0.02元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益156898.20万元,未分配利润75466.42万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产174658.97万元,负债17760.77万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入325,753,716.96218,756,705.1108,322,506.68835,509,951.28
营业总成本349,459,875.73230,768,163.87111,604,696.36517,162,283.47
营业利润-7,148,791.12-1,148,670.122,476,875.18321,683,932.11
利润总额-10,897,164.57-1,333,256.492,452,205.56316,533,369.79
净利润-2,653,779.13-1,779,323.092,068,381.83243,072,734.38
其他综合收益----2,126,356.94
综合收益总额-2,653,779.13-1,779,323.092,068,381.83240,946,377.44
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计698,317,762.17734,975,599.31785,429,083.52822,169,778.54
非流动资产合计1,048,271,915.681,033,653,592.791,033,439,375.711,016,824,783.44
资产总计1,746,589,677.851,768,629,192.11,818,868,459.231,838,994,561.98
流动负债合计138,449,534.46158,648,739.59172,287,885.78194,512,240.38
非流动负债合计39,158,178.9240,124,03241,240,323.0241,210,453
负债合计177,607,713.38198,772,771.59213,528,208.8235,722,693.38
归属于母公司股东权益合计1,568,981,964.471,569,856,420.511,605,340,250.431,603,271,868.6
股东权益合计1,568,981,964.471,569,856,420.511,605,340,250.431,603,271,868.6
负债和股东权益合计1,746,589,677.851,768,629,192.11,818,868,459.231,838,994,561.98
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计363,984,280.59244,745,648.7137,056,378.39690,399,431.17
经营活动现金流出小计254,855,401.29184,785,873.1584,910,887.82663,446,067.16
经营活动产生的现金流量净额109,128,879.359,959,775.5552,145,490.5726,953,364.01
投资活动现金流入小计463,146,798.09262,033,719.33191,461,695.621,296,612,507.2
投资活动现金流出小计477,234,306.39253,006,399.6185,429,006.71,425,220,153.31
投资活动产生的现金流量净额-14,087,508.39,027,319.72106,032,688.92-128,607,646.11
筹资活动现金流入小计91,513.1552,744.97-21,600,316.5
筹资活动现金流出小计31,636,12531,636,125-90,672,638.89
筹资活动产生的现金流量净额-31,544,611.85-31,583,380.03--69,072,322.39
汇率变动对现金及现金等价物的影响61,882.52577,186.55256,793.38111,376.86
现金及现金等价物净增加额63,558,641.6737,980,901.79158,434,972.87-170,615,227.63
期末现金及现金等价物余额194,291,924.17168,714,184.29289,168,255.37130,733,282.5
TOP↑